AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
By Elana Gotkine HealthDay Reporter
MONDAY, April 8, 2024 -- An exosome-based liquid biopsy assay can distinguish patients with pancreatic ductal adenocarcinoma (PDAC) from healthy donors (HDs), according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.
Caiming Xu, M.D., Ph.D., from the Beckman Research Institute of The City of Hope in Monrovia, California, and colleagues performed a real-time quantitative polymerase chain reaction-based assay using the plasma biospecimen from four prospective cohorts. The performance of the microRNA (miRNA) signature was also examined in conjunction with plasma CA19-9 for detecting early-stage PDAC.
The researchers found that two distinct panels of cell-free-miRNAs and exosomal-miRNAs robustly distinguished patients with PDAC from HDs in the training cohort from Japan. The signature resulting from combining these panels exhibited a notable ability to distinguish PDAC from HD with substantial accuracy in the training cohort (area under the curve [AUC], 0.98). This signature was successfully validated and evaluated in three independent cohorts from the United States, Korea, and China (AUCs, 0.93, 0.91, and 0.88, respectively). When the signature was combined with CA19-9 in the U.S. cohort, the overall diagnostic performance of this liquid biopsy assay significantly improved early detection of PDAC (AUC, 0.97; sensitivity and specificity, 0.95 and 0.96, respectively).
"We have established an exosome-based signature that combines exosomal microRNAs and cell-free DNA to robustly identify patients with early-stage pancreatic cancer," Xu said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women
FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.